Menadione

甲萘醌

Report date: 2024/12/02 09:30:06
NME

Base Information

Drug NameMenadione
Drug Alias NameVitamin K3维生素K3甲荼锟甲奈昆亚硫酸氢钠甲萘醌 +[6] 
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonistsProtein tyrosine phosphatase inhibitors
TargetsEpidermal growth factor receptor erbB1Protein tyrosine phosphatase
Therapy Area/IndicationsExanthemaVitamin K Deficiency BleedingHypoprothrombinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSwitzerland +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanySpectrum Pharmaceuticals Inc
Active IndicationsVitamin K Deficiency Bleeding
Inactive IndicationsExanthemaHypoprothrombinemias

Other Information

ATC CodeB02BA02
Related LinksWikipediaDrugBankKEGG